Macomber Lori
SEC CIK 1968671 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | EVP, CFO, Treas | 85.1K | — | $10.2K | 4 | 2025-01-31 | 2026-02-03 |
Most active insiders at KPTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| 2 | Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| 3 | Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| 4 | Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| 5 | Mano Michael | SVP, GC, Sec | — | $35.7K |
| 6 | Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| 7 | Abate Kristin | CAO | — | $10.0K |
| 8 | Su Zhen | Dir | — | — |
| 9 | Oliger Christy J. | Dir | — | — |
| 10 | Schor Chen | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-04 | 2026-02-03 | KPTI | Karyopharm Therapeutics Inc. | Macomber Lori | EVP, CFO, Treas | S - Sale | $6.30 | -1,626 | 85.1K | -2% | -$10.2K | |
| 2026-02-03 | 2026-01-31 | KPTI | Karyopharm Therapeutics Inc. | Macomber Lori | EVP, CFO, Treas | A - Grant | $0.00 | +32.4K | 86.7K | +60% | $0 | |
| 2025-10-16 | 2025-10-15 | KPTI | Karyopharm Therapeutics Inc. | Macomber Lori | EVP, CFO, Treas | A - Grant | $0.00 | +43.6K | 54.3K | +409% | $0 | |
| D | 2025-02-03 | 2025-01-31 | KPTI | Karyopharm Therapeutics Inc. | Macomber Lori | EVP, CFO, Treas | A - Grant | $0.00 | +160.0K | 160.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations